bluebird bio, Inc.
TIM3 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
Last updated:
Abstract:
The invention provides improved genome editing compositions and methods for editing a TIM3 gene. The invention further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of, a cancer, an infectious disease, an autoimmune disease, an inflammatory disease, or an immunodeficiency.
Status:
Application
Type:
Utility
Filling date:
23 Aug 2017
Issue date:
29 Aug 2019